Status: Recruiting
Nalmefene Implant in Healthy Subjects
The goal of this clinical trial is to learn how safe either one or two nalmefene implants are after remaining implanted for 4 or 12 weeks. Additionally the pharmacokinetics (PK), how fast the drug is absorbed into the body and how long it remains in the body, will also be studies. The data collected in this healthy volunteer study will inform the Sponsor on how best to proceed with future trials in the intended patient population.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: ReacX Pharmaceuticals, Inc.Updated: Apr 6, 2026Locations: 1
Eligibility criteria
Male or female, non-smoker, ≥18 and ≤55 years of age, with body mass index (BMI)... [+4]
Any clinically significant abnormal finding at physical examination at screening... [+22]